Pharma Focus Asia
KP - Sustainable Packaging Solutions

Cambrex Plans to Increase Development Capacity and Resources in North America


Cambrex Corporation announced its plans to expand chemical and analytical development capabilities at its Charles City, Iowa Plant.


The project is intended to increase company’s development capacity and resources in North America. The expansion includes an additional 2, 000sq.ft. of laboratory space for development projects.

The building, installation, and validation of equipment are expected to be completed by Q1 2018.  The development capacity involves the addition of 14 chemists’ jobs.

In parallel, a new 11, 000 sq.ft. analytical laboratory and 400 sq.ft. a pilot plant with a total reactor capacity of 4, 000 liters are currently being completed. These expansions at High Point will create up to 18 new jobs.

Cambrex’s Charles City, Iowa facility is located on a 45-acre site and manufactures a wide range of APIs and pharmaceutical intermediates, including highly potent molecules and controlled substances.


NameCambrex Corporation
Parties InvolvedCambrex Corporation
ScheduleQ1 2018
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?